Clover Health Investments, Corp. (CLOV) vs MBX Biosciences, Inc. Common Stock (MBX)

A side-by-side comparison of Clover Health Investments, Corp. and MBX Biosciences, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Clover Health Investments, Corp. logo
CLOV
Clover Health Investments, Corp.
$2.41B
$4.65HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
MBX Biosciences, Inc. Common Stock logo
MBX
MBX Biosciences, Inc. Common Stock
$2.73B
$57.29HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT

Total return — CLOV vs MBX

growth of $100 · dividends reinvested · last 2y
CLOV +56.5% (+25.1%/yr)MBX +147.5% (+57.3%/yr)MBX compounded faster over this window
100200300Start $10020252026$157$248
CLOV MBX

CLOV vs MBX: by the numbers

  • •MBX is the larger company ($2.73B vs $2.41B market cap).
  • •Both run net losses; MBX's is the smaller (0.00% vs -0.74% net margin).

Metrics side by side

Valuation

MetricCLOVMBX
Forward P/E82.89N/A
P/S ratio0.97N/A
P/B ratio6.406.66
FCF yield3.08%N/A

Profitability

MetricCLOVMBX
Gross margin18.57%0.00%
Operating margin-0.74%0.00%
Net margin-0.74%0.00%
ROE-4.88%-25.47%
ROIC-4.62%-28.60%

Growth (annualized)

MetricCLOVMBX
Revenue CAGR (5Y)21.18%N/A
Total return CAGR (5Y)-8.36%N/A

Go deeper

Full CLOV analysisFull MBX analysisInteractive comparison tool

Dig into the metrics

Clover Health Investments ROEMBX Biosciences, Inc. Common Stock ROEClover Health Investments operating marginMBX Biosciences, Inc. Common Stock operating marginClover Health Investments revenue growthMBX Biosciences, Inc. Common Stock revenue growthClover Health Investments free cash flowMBX Biosciences, Inc. Common Stock free cash flow

Clover Health Investments & MBX Biosciences, Inc. Common Stock appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.